Profile data is unavailable for this security.
About the company
TTK Healthcare Limited is an India-based company, which provides consumer and healthcare products. The Company's segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods and Others. The Animal Welfare segment comprises products for veterinary use. The Consumer Products segment comprises marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, good home range of scrubbers, air fresheners and various others. Its brands also include Skore and HUG n WAG. The Medical Devices segment includes artificial heart valves, orthopedic implants and others. The Protective Devices segment comprises manufacturing and marketing of male contraceptives and other allied products. The Foods segment comprises manufacturing and marketing of food products. Under the brand name Fryums, extruded products such as papads are offered to its business to business and export customers. The Others segment includes printing and publishing of maps and atlases.
- Revenue in INR (TTM)7.53bn
- Net income in INR628.42m
- Incorporated1958
- Employees1.29k
- LocationTTK Healthcare Ltd6, Cathedral RoadCHENNAI 600086IndiaIND
- Phone+91 4 428116108
- Fax+91 4 428114307
- Websitehttps://ttkhealthcare.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EQL Pharma AB | 2.09bn | 179.91m | 12.34bn | 21.00 | 70.14 | 8.77 | -- | 5.90 | 0.7642 | 0.7642 | 8.88 | 6.12 | 0.8012 | 1.74 | 4.80 | 12,579,430.00 | 6.89 | 9.02 | 11.90 | 15.27 | 43.55 | 37.95 | 8.59 | 8.29 | 0.5694 | 8.88 | 0.4032 | -- | 1.64 | 39.64 | -26.57 | -- | 32.73 | -- |
| CM Hospitalar SA | 175.68bn | 5.10bn | 12.54bn | 7.00k | 2.39 | 0.2404 | 1.34 | 0.0714 | 1.04 | 1.04 | 36.93 | 10.32 | 1.12 | 5.56 | 4.67 | 1,606,019.00 | 3.25 | 4.00 | 4.51 | 6.15 | 15.13 | 15.89 | 2.90 | 3.50 | 1.68 | 1.56 | 0.576 | -- | 26.72 | 33.22 | 38.57 | 60.22 | -2.72 | -- |
| Hemas Holdings PLC | 33.57bn | 1.69bn | 14.35bn | 5.83k | 8.51 | 1.20 | 6.47 | 0.4273 | 10.24 | 10.24 | 203.85 | 72.79 | 1.27 | 3.33 | 4.70 | 20,874,320.00 | 6.61 | 5.71 | 12.51 | 10.41 | 29.60 | 29.36 | 5.23 | 4.94 | 1.01 | 5.01 | 0.2236 | 28.30 | 6.74 | 13.67 | 43.10 | 12.64 | -2.33 | 13.12 |
| Salus Ljubljana dd | 56.25bn | 1.04bn | 18.82bn | 144.00 | 18.17 | 2.68 | 11.37 | 0.3347 | 108.99 | 108.99 | 5,902.00 | 738.12 | 2.95 | 10.39 | 7.61 | -- | 5.44 | 6.59 | 12.52 | 13.64 | 10.45 | 8.50 | 1.85 | 2.28 | 0.8165 | 18.49 | 0.2107 | 60.73 | 20.93 | 18.82 | -20.58 | 19.37 | 69.24 | 13.60 |
| Shanghai Kai Kai Industrial Co Ltd | 11.06bn | 608.09m | 18.96bn | 492.00 | 40.85 | 3.48 | -- | 1.71 | 0.2172 | 0.2172 | 3.95 | 2.55 | 0.7819 | 10.68 | 3.50 | 1,950,902.00 | 4.49 | 2.39 | 6.98 | 3.53 | 18.63 | 23.54 | 5.74 | 3.20 | 1.28 | -- | 0.0355 | 26.33 | 3.46 | 1.06 | -1.57 | 2.21 | 34.01 | 1.72 |
| TTK Healthcare Ltd | 7.53bn | 628.42m | 20.16bn | 1.29k | 32.08 | 2.01 | 26.57 | 2.68 | 44.48 | 44.48 | 532.85 | 708.35 | 0.6351 | 3.73 | 8.43 | -- | 5.30 | 5.06 | 6.40 | 7.02 | 55.07 | 54.71 | 8.35 | 5.47 | 5.01 | 8.81 | 0.0223 | 31.47 | 3.82 | 3.70 | 40.69 | 20.86 | 19.12 | 14.87 |
| Amway (Malaysia) Holdings Berhad | 24.17bn | 2.30bn | 21.45bn | 345.00 | 9.33 | 4.52 | 8.43 | 0.8876 | 0.7853 | 0.7853 | 8.26 | 1.62 | 2.46 | 6.18 | 32.83 | 3,934,806.00 | 23.39 | 12.97 | 49.88 | 27.16 | 26.74 | 21.36 | 9.51 | 5.02 | 1.18 | 235.20 | 0.0363 | 88.80 | -7.03 | 7.69 | 50.79 | 16.29 | 7.92 | 0.00 |
| Beihai Gofar Chuanshan Biological Co Ltd | 4.09bn | -1.06bn | 26.70bn | 463.00 | -- | 2.70 | -- | 6.52 | -0.1755 | -0.1755 | 0.6775 | 1.63 | 0.3258 | 3.17 | 1.49 | 767,059.10 | -8.32 | -0.517 | -9.99 | -0.6208 | 22.89 | 24.59 | -25.54 | -1.44 | 2.60 | -63.64 | 0.0336 | -- | -19.69 | 10.46 | -336.10 | -- | -17.59 | -- |
| Shanghai Pioneer Holding Ltd | 18.08bn | 1.68bn | 27.02bn | 345.00 | 15.06 | 2.33 | 15.83 | 1.49 | 0.1334 | 0.1334 | 1.43 | 0.8639 | 1.01 | 2.43 | 3.64 | 4,901,141.00 | 8.32 | 8.90 | 11.94 | 12.49 | 42.65 | 48.69 | 8.23 | 9.09 | 1.56 | 144.69 | 0.0678 | 66.22 | 0.6833 | -0.7199 | -38.07 | 11.49 | 120.23 | -- |
| Jiangsu Lianhuan Pharmaceutical Co. Ltd | 25.94bn | 1.57bn | 27.40bn | 1.30k | 17.47 | 1.71 | -- | 1.06 | 0.4767 | 0.4767 | 7.86 | 4.86 | 0.813 | 3.96 | 4.60 | 1,736,789.00 | 5.54 | 5.93 | 10.82 | 11.25 | 47.56 | 53.26 | 6.81 | 7.82 | 0.8523 | 7.35 | 0.3362 | 30.64 | 11.20 | 16.36 | -4.50 | 12.91 | 9.35 | 13.97 |
| Holder | Shares | % Held |
|---|---|---|
| Jupiter Asset Management Ltd.as of 29 Feb 2024 | 260.64k | 1.85% |
| Abakkus Asset Manager LLPas of 31 Dec 2023 | 159.59k | 1.13% |
| State Board of Administration of Florida Retirement Systemas of 30 Jun 2023 | 4.82k | 0.03% |
